Skip to Content
Merck
  • Stabilization of the base-off forms of vitamin B(12) and coenzyme B(12) by encapsulation of the alpha-axial 5,6-dimethylbenzimidazole ligand with cucurbit[7]uril.

Stabilization of the base-off forms of vitamin B(12) and coenzyme B(12) by encapsulation of the alpha-axial 5,6-dimethylbenzimidazole ligand with cucurbit[7]uril.

Dalton transactions (Cambridge, England : 2003) (2009-04-22)
Ruibing Wang, Brendan C Macgillivray, Donal H Macartney
ABSTRACT

Cucurbit[7]uril (CB[7]) forms very stable complexes with the alpha-axial 5,6-dimethylbenzimidazole (alpha-DMB) nucleotide base when dissociated from the Co(III) center in vitamin B(12) (CNCbl, K(CB[7]) = (7.5 +/- 0.5) x 10(4) dm(3) mol(-1)) and coenzyme B(12) (AdoCbl, K(CB[7]) = (3.02 +/- 0.35) x 10(6) dm(3) mol(-1)). The inclusion of alpha-DMB ligand facilitates its release from the metal center and its subsequent protonation, with significantly higher pK(base-off) values of 3.77 and 6.61, than determined for the free CNCbl (0.11) and AdoCbl (2.67), respectively. Addition of CB[7] to the base-on form of CNCbl at pH 2 provides for a direct measurement of the rate constant for the dissociation of the alpha-DMB ligand from the Co center (k = (4.6 +/- 0.2) x 10(-2) s(-1), DeltaH = 93 +/- 2 kJ mol(-1), DeltaS = +41 +/- 6 J K(-1) mol(-1)). The beta-axial 5'-deoxyadenosyl ligand (beta-Ado) on coenzyme B(12) is bound more weakly by a second CB[7] host (K(CB[7]) = (1.1 +/- 0.2) x 10(3) dm(3) mol(-1)), however inclusion of the beta-Ado ligand has no effect on the kinetics of its heterolytic photodissociation from the Co(III) center.